A Tumor Lysis Syndrome Risk Assessment and Its Impact on Patients
08/09/2022
In an interview, Nicholas Short, MD, shares objectives on the design and benefits of MD Anderson’s Tumor Lysis Syndrome clinical assessment for patient risk and impact on patient care.